Margarete Karg



Organisation


Medizinische Klinik 5 - Hämatologie und Internistische Onkologie


Publications (Download BibTeX)


Kittler, J., Sommer, J., Fischer, A., Britting, S., Karg, M., Bock, B.,... Bosch, J.J. (2019). Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines. Oncotarget, 10(19), 1812-1828.
Rossner, S., Czerwinski, T., Mark, C., Gross, S., Karg, M., Bosch, J.,... Bosch-Voskens, C. (2018). Ex vivo expanded NK Cells from Melanoma Patients receive their Migration in a 3D Model and lyse autologous Melanoma Cells. (pp. 52-52).
Karg, M., Bosch, A., Kannenkeril, D., Striepe, K., Ott, C., Schneider, M.P.,... Schmieder, R. (2018). SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial. Cardiovascular Diabetology, 17(1), 5. https://dx.doi.org/10.1186/s12933-017-0654-z
Ott, C., Jumar, A., Striepe, K., Friedrich, S., Karg, M., Bramlage, P., & Schmieder, R. (2017). A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation. Cardiovascular Diabetology, 16(1), 26. https://dx.doi.org/10.1186/s12933-017-0510-1
Striepe, K., Jumar, A., Ott, C., Karg, M., Schneider, M., Kannenkeril, D., & Schmieder, R. (2017). Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus. Circulation, 136(12), 1167-1169. https://dx.doi.org/10.1161/CIRCULATIONAHA.117.029529
Schneider, A., Schwab, J., Karg, M., Kalizki, T., Reinold, A., Schneider, M.,... Schmidt, B.M.W. (2017). Low-dose eplerenone decreases left ventricular mass in treatment-resistant hypertension. Journal of Hypertension, 35(5), 1086-1092. https://dx.doi.org/10.1097/HJH.0000000000001264

Last updated on 2018-02-12 at 22:51